Pharma IQ Talking Heads - Global Pharmaceutical Contract Manufacturing Roundtable 2012
Add bookmarkWe respect your privacy, by clicking "Download Your Copy" you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.
Contract Manufacturing in Pharmaceuticals continues to increase…
Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny. As a result there has been an increase in the need for a reduction in the size and cost of internal manufacturing and sourcing of cheaper products from external parties.
Recent reports indicate that the global pharmaceutical contract manufacturing market will be worth US$40.7 billion by 2015 - Are you effectively leveraging external supply and managing the risks involved to make the most of your outsourcing options?
As the pharmaceutical industry relies on faster drug development and cost containment to maintain growth, there has never been a more important time to develop strategic CMO alliances to facilitate entry into emerging markets, reduce costs and increase product revenue. But with so many CMOs to choose from, how can you guarantee that you have the right partner to provide the services you require with minimal risk and maximum efficiency?
[inlinead]
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
